2018 and Beyond: United Kingdom Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in United Kingdom witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in United Kingdom and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on United Kingdom healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the United Kingdom healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of United Kingdom pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in United Kingdom and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on United Kingdom healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the United Kingdom healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of United Kingdom pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 United Kingdom Pharmaceutical and Healthcare Industry Snapshot
2.2 United Kingdom Pharmaceuticals Market Overview
3 UNITED KINGDOM PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in United Kingdom
3.2 Drivers and Restraints
3.2.1 Market Drivers in United Kingdom Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in United Kingdom Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 UNITED KINGDOM PHARMACEUTICAL MARKET OUTLOOK
4.1 United Kingdom Pharmaceutical Sales, $ Million, 2015- 2025
4.2 United Kingdom Pharmaceutical Exports, $ million, 2015- 2025
4.3 United Kingdom Pharmaceutical Imports, $ Million, 2015- 2025
4.4 United Kingdom (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 United Kingdom (% contribution) to Global Pharmaceutical Market size, 2017
4.6 United Kingdom Prescription Drug Sales, $ Million, 2015- 2025
4.7 United Kingdom Generic Drug Sales, $ Million, 2015- 2025
5 UNITED KINGDOM HEALTHCARE MARKET OUTLOOK
5.1 United Kingdom Healthcare Expenditure Outlook, 2015- 2025
5.2 United Kingdom Healthcare Expenditure (% of GDP), 2015- 2025
5.3 United Kingdom Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 United Kingdom Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in United Kingdom, 2015- 2025
6 UNITED KINGDOM HEALTHCARE MARKET STATISTICS
6.1 United Kingdom Mortality by Disease Category, 2017
6.2 Number of Hospitals in United Kingdom, 2007- 2017
6.3 Number of Hospital Beds in United Kingdom, 2007- 2017
6.4 Physicians Count in United Kingdom, 2007- 2017
6.5 Pharmacists Count in United Kingdom, 2007- 2017
7 UNITED KINGDOM CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in United Kingdom, 2017
7.2 Ongoing Clinical Trials by Disease Category in United Kingdom, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 UNITED KINGDOM DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 United Kingdom Population Forecast by Age Group, 2005- 2025
8.2 United Kingdom Population Forecast by Location, 2005- 2025
8.3 United Kingdom GDP Forecast, 2005- 2025
8.4 United Kingdom GDP Per Capita Forecast, 2005- 2025
8.5 United Kingdom Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN UNITED KINGDOM PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 United Kingdom Pharmaceutical and Healthcare Industry Snapshot
2.2 United Kingdom Pharmaceuticals Market Overview
3 UNITED KINGDOM PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in United Kingdom
3.2 Drivers and Restraints
3.2.1 Market Drivers in United Kingdom Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in United Kingdom Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 UNITED KINGDOM PHARMACEUTICAL MARKET OUTLOOK
4.1 United Kingdom Pharmaceutical Sales, $ Million, 2015- 2025
4.2 United Kingdom Pharmaceutical Exports, $ million, 2015- 2025
4.3 United Kingdom Pharmaceutical Imports, $ Million, 2015- 2025
4.4 United Kingdom (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 United Kingdom (% contribution) to Global Pharmaceutical Market size, 2017
4.6 United Kingdom Prescription Drug Sales, $ Million, 2015- 2025
4.7 United Kingdom Generic Drug Sales, $ Million, 2015- 2025
5 UNITED KINGDOM HEALTHCARE MARKET OUTLOOK
5.1 United Kingdom Healthcare Expenditure Outlook, 2015- 2025
5.2 United Kingdom Healthcare Expenditure (% of GDP), 2015- 2025
5.3 United Kingdom Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 United Kingdom Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in United Kingdom, 2015- 2025
6 UNITED KINGDOM HEALTHCARE MARKET STATISTICS
6.1 United Kingdom Mortality by Disease Category, 2017
6.2 Number of Hospitals in United Kingdom, 2007- 2017
6.3 Number of Hospital Beds in United Kingdom, 2007- 2017
6.4 Physicians Count in United Kingdom, 2007- 2017
6.5 Pharmacists Count in United Kingdom, 2007- 2017
7 UNITED KINGDOM CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in United Kingdom, 2017
7.2 Ongoing Clinical Trials by Disease Category in United Kingdom, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 UNITED KINGDOM DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 United Kingdom Population Forecast by Age Group, 2005- 2025
8.2 United Kingdom Population Forecast by Location, 2005- 2025
8.3 United Kingdom GDP Forecast, 2005- 2025
8.4 United Kingdom GDP Per Capita Forecast, 2005- 2025
8.5 United Kingdom Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN UNITED KINGDOM PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
